We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+8.26%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.6B
AUM Growth
+$709K
Cap. Flow
-$355M
Cap. Flow %
-22.18%
Top 10 Hldgs %
13.02%
Holding
382
New
91
Increased
82
Reduced
72
Closed
78

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 14.78%
2 Technology 12.3%
3 Healthcare 11.32%
4 Financials 7.88%
5 Industrials 6.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHW
226
Charles Schwab
SCHW
$187B
$1.75M 0.11%
+57,332
New +$1.66M
ABMD
227
DELISTED
Abiomed Inc
ABMD
$1.7M 0.11%
+23,779
New +$1.29M
GS icon
228
Goldman Sachs
GS
$303B
$1.7M 0.11%
9,021
+822
+10% +$153K
VC icon
229
Visteon
VC
$2.78B
$1.69M 0.11%
+17,562
New +$1.75M
F icon
230
Ford
F
$55.7B
$1.64M 0.1%
+101,591
New +$1.6M
NKE icon
231
Nike
NKE
$61.9B
$1.62M 0.1%
32,306
ALDR
232
DELISTED
Alder Biopharmaceuticals
ALDR
$1.61M 0.1%
55,763
+6,325
+13% +$174K
TWOU
233
DELISTED
2U Inc
TWOU
$1.43M 0.09%
1,868
-4,103
-69% -$2.35M
TIF
234
DELISTED
Tiffany & Co.
TIF
$1.3M 0.08%
14,826
-47,333
-76% -$4.23M
ONCE
235
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.29M 0.08%
+16,684
New +$961K
WFC icon
236
Wells Fargo
WFC
$264B
$1.25M 0.08%
+22,991
New +$1.24M
OLED icon
237
Universal Display
OLED
$4.19B
$1.21M 0.08%
25,795
-19,159
-43% -$679K
DCOY
238
Decoy Therapeutics
DCOY
$2.09M
0
INSM icon
239
Insmed
INSM
$28.6B
$1.19M 0.07%
+57,124
New +$1.01M
STRR
240
DELISTED
Star Equity Holdings
STRR
$1.14M 0.07%
5,000
CPHD
241
DELISTED
Cepheid Inc
CPHD
$1.13M 0.07%
19,776
-116,909
-86% -$6.58M
NEO icon
242
NeoGenomics
NEO
$2.13B
$1.03M 0.06%
220,961
+51,485
+30% +$224K
LOXO
243
DELISTED
Loxo Oncology, Inc
LOXO
$1.03M 0.06%
82,737
+22,232
+37% +$277K
UTIW
244
DELISTED
UTI WORLDWIDE INC
UTIW
$999K 0.06%
+81,254
New +$1.01M
EVFM
245
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$969K 0.06%
1,311
-25
-2% -$16K
CRM icon
246
Salesforce
CRM
$158B
$916K 0.06%
+13,706
New +$850K
TWC
247
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
$808K 0.05%
+5,389
New +$804K
GILD icon
248
Gilead Sciences
GILD
$165B
$807K 0.05%
8,220
-8,899
-52% -$904K
CSGP icon
249
CoStar Group
CSGP
$12.3B
$677K 0.04%
+34,220
New +$646K
MXPT
250
DELISTED
MaxPoint Interactive, Inc.
MXPT
$671K 0.04%
+17,500
New +$692K

Similar funds

Nicholas Investment Partners's Q1 2015 Portfolio in Review

As of Q1 2015, Nicholas Investment Partners held 382 positions worth $1.6B, up 0.04% from $1.6B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Nicholas Investment Partners withdrew a net $355M in Q1 2015, closing 78 positions and reducing 72 holdings. Its most notable exit was RF MICRO DEVICES INC, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Nicholas Investment Partners opened a new position in ACTAVIS PLC Pfd Conv Ser A (Irl) worth $13.6M.

  • Nicholas Investment Partners's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 13,480 shares worth $13.6M.
  • Nicholas Investment Partners added most to RECEPTOS INC COM STK (DE) in Q1 2015, an estimated $4.78M increase.
  • Nicholas Investment Partners's biggest Q1 2015 reduction was Las Vegas Sands, cutting an estimated $27.9M.
  • Nicholas Investment Partners fully exited RF MICRO DEVICES INC in Q1 2015, selling an estimated $20M.
  • Nicholas Investment Partners's ten largest holdings make up 13% of its $1.6B portfolio in Q1 2015.
  • Nicholas Investment Partners opened 91 new positions and closed 78 in Q1 2015.
  • Nicholas Investment Partners's portfolio value rose 0.04% quarter-over-quarter to $1.6B.

Based on Nicholas Investment Partners's 13F filing for Q1 2015, filed 15 May 2015.